MannKind Corp
NASDAQ:MNKD

Watchlist Manager

MannKind Corp

NASDAQ:MNKD

Watchlist

Dividends

Price: 6.85 USD 8.73%

Market Cap: 1.9B USD

Have any thoughts about
MannKind Corp?

Write Note

Write Note Create Alert Ask AI

Add Note Why Create Notes?

Capture your thoughts

Note Buy Sell Hold Pass

US	Johnson & Johnson NYSE:JNJ	Pharmaceuticals
US	Berkshire Hathaway Inc NYSE:BRK.A	Financial Services
US	Bank of America Corp NYSE:BAC	Banking
US	Mastercard Inc NYSE:MA	Technology
US	UnitedHealth Group Inc NYSE:UNH	Health Care
US	Exxon Mobil Corp NYSE:XOM	Energy
US	Pfizer Inc NYSE:PFE	Pharmaceuticals
US	Palantir Technologies Inc NYSE:PLTR	Technology
US	Nike Inc NYSE:NKE	Textiles, Apparel & Luxury Goods
US	Visa Inc NYSE:V	Technology
CN	Alibaba Group Holding Ltd NYSE:BABA	Retail
US	3M Co NYSE:MMM	Industrial Conglomerates
US	JPMorgan Chase & Co NYSE:JPM	Banking
US	Coca-Cola Co NYSE:KO	Beverages
US	Walmart Inc NYSE:WMT	Retail
US	Verizon Communications Inc NYSE:VZ	Telecommunication

Add Price Alert

Price Target:

Last Price: 6.85 USD

We'll email you a reminder when the closing price reaches USD.

If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Peter Lynch

Track and Analyze Performance

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.

Continuous Learning and Adaptation

Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.

Boost Decision Confidence

With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.

Why create notes?

Back

Delete Note

Do you really want to delete this note?
This action cannot be undone.

Remove price alert for reaching

Delete

Cancel

MNKD Alert

MannKind Corp

6.85

+0.55 (+8.73%)

52 Week Range	3.25 7.44
Price Target

We'll email you a reminder when the closing price reaches USD.

Save Alert

Choose the stock you wish to monitor with a price alert.

	Johnson & Johnson NYSE:JNJ	US
	Berkshire Hathaway Inc NYSE:BRK.A	US
	Bank of America Corp NYSE:BAC	US
	Mastercard Inc NYSE:MA	US
	UnitedHealth Group Inc NYSE:UNH	US
	Exxon Mobil Corp NYSE:XOM	US
	Pfizer Inc NYSE:PFE	US
	Palantir Technologies Inc NYSE:PLTR	US
	Nike Inc NYSE:NKE	US
	Visa Inc NYSE:V	US
	Alibaba Group Holding Ltd NYSE:BABA	CN
	3M Co NYSE:MMM	US
	JPMorgan Chase & Co NYSE:JPM	US
	Coca-Cola Co NYSE:KO	US
	Walmart Inc NYSE:WMT	US
	Verizon Communications Inc NYSE:VZ	US

Delete Alert

This alert will be permanently deleted.

Remove note

Delete

Cancel

Ask me anything about

MannKind Corp

What unique competitive advantages
does MannKind Corp hold over its rivals?

What risks and challenges
does MannKind Corp face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Provide an overview of the primary business activities
of MannKind Corp.

What unique competitive advantages
does MannKind Corp hold over its rivals?

What risks and challenges
does MannKind Corp face in the near future?

Has there been any significant insider trading activity
in MannKind Corp recently?

Summarize the latest earnings call
of MannKind Corp.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for MannKind Corp.

Provide P/S
for MannKind Corp.

Provide P/E
for MannKind Corp.

Provide P/OCF
for MannKind Corp.

Provide P/FCFE
for MannKind Corp.

Provide P/B
for MannKind Corp.

Provide EV/S
for MannKind Corp.

Provide EV/GP
for MannKind Corp.

Provide EV/EBITDA
for MannKind Corp.

Provide EV/EBIT
for MannKind Corp.

Provide EV/OCF
for MannKind Corp.

Provide EV/FCFF
for MannKind Corp.

Provide EV/IC
for MannKind Corp.

Show me price targets
for MannKind Corp made by professional analysts.

What are the Revenue projections
for MannKind Corp?

How accurate were the past Revenue estimates
for MannKind Corp?

What are the Net Income projections
for MannKind Corp?

How accurate were the past Net Income estimates
for MannKind Corp?

What are the EPS projections
for MannKind Corp?

How accurate were the past EPS estimates
for MannKind Corp?

What are the EBIT projections
for MannKind Corp?

How accurate were the past EBIT estimates
for MannKind Corp?

Compare the revenue forecasts
for MannKind Corp with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of MannKind Corp and its key competitors using the latest financial data.

Compare historical revenue growth rates
of MannKind Corp against its competitors.

Analyze the profit margins
(gross, operating, and net) of MannKind Corp compared to its peers.

Compare the P/E ratios
of MannKind Corp against its peers.

Discuss the investment returns and shareholder value creation
comparing MannKind Corp with its peers.

Analyze the financial leverage
of MannKind Corp compared to its main competitors.

Show all profitability ratios
for MannKind Corp.

Provide ROE
for MannKind Corp.

Provide ROA
for MannKind Corp.

Provide ROIC
for MannKind Corp.

Provide ROCE
for MannKind Corp.

Provide Gross Margin
for MannKind Corp.

Provide Operating Margin
for MannKind Corp.

Provide Net Margin
for MannKind Corp.

Provide FCF Margin
for MannKind Corp.

Show all solvency ratios
for MannKind Corp.

Provide D/E Ratio
for MannKind Corp.

Provide D/A Ratio
for MannKind Corp.

Provide Interest Coverage Ratio
for MannKind Corp.

Provide Altman Z-Score Ratio
for MannKind Corp.

Provide Quick Ratio
for MannKind Corp.

Provide Current Ratio
for MannKind Corp.

Provide Cash Ratio
for MannKind Corp.

What is the historical Revenue growth
over the last 5 years for MannKind Corp?

What is the historical Net Income growth
over the last 5 years for MannKind Corp?

What is the current Free Cash Flow
of MannKind Corp?

Discuss the annual earnings per share (EPS)
trend over the past five years for MannKind Corp.

EV/EBITDA
Enterprise Value to EBITDA

32.9

Current

-16

Median

4.2

Industry

Higher than median

Higher than industry value

Enterprise Value to EBITDA (EV/EBITDA) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s cash earnings less non-cash expenses. EBITDA can be misleading at times, especially for companies that are highly capital intensive.

EV/EBITDA

32.9

Enterprise Value

2.1B USD

EBITDA

63.7m USD

All Countries

Forward Multiples

			Market Cap	EV/EBITDA
US		MannKind Corp NASDAQ:MNKD	1.9B USD	32.9
FR		Pharnext SCA OTC:PNEXF	6T USD	-219 476
US		Abbvie Inc NYSE:ABBV	310.3B USD	15.2
US		Amgen Inc NASDAQ:AMGN	141.6B USD	16
US		Gilead Sciences Inc NASDAQ:GILD	115.3B USD	10.2
US		Vertex Pharmaceuticals Inc NASDAQ:VRTX	102.4B USD	21
US	E	Epizyme Inc F:EPE	94.1B EUR	-514.8
AU		CSL Ltd ASX:CSL	134.4B AUD	19.7
US		Regeneron Pharmaceuticals Inc NASDAQ:REGN	77.3B USD	15.1
US	S	Seagen Inc F:SGT	39.3B EUR	-58.8
NL		argenx SE XBRU:ARGX	35.8B EUR	-108.8

				EBITDA Growth	EV/EBITDA to Growth
US		MannKind Corp NASDAQ:MNKD	Average EV/EBITDA: 18.6 32.9	N/A	N/A
FR		Pharnext SCA OTC:PNEXF	Negative Multiple: -219 476	N/A	N/A
US		Abbvie Inc NYSE:ABBV	15.2	29%	0.5
US		Amgen Inc NASDAQ:AMGN	16	62%	0.3
US		Gilead Sciences Inc NASDAQ:GILD	10.2	16%	0.6
US		Vertex Pharmaceuticals Inc NASDAQ:VRTX	21	43%	0.5
US	E	Epizyme Inc F:EPE	Negative Multiple: -514.8	N/A	N/A
AU		CSL Ltd ASX:CSL	19.7	42%	0.5
US		Regeneron Pharmaceuticals Inc NASDAQ:REGN	15.1	35%	0.4
US	S	Seagen Inc F:SGT	Negative Multiple: -58.8	N/A	N/A
NL		argenx SE XBRU:ARGX	Negative Multiple: -108.8	N/A	N/A

EV/EBITDA Forward Multiples

Forward EV/EBITDA multiple is a version of the EV/EBITDA ratio that uses forecasted EBITDA for the EV/EBITDA calculation. 1-Year, 2-Years, and 3-Years forwards use EBITDA forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward

EV/EBITDA

N/A

2-Years Forward

EV/EBITDA

N/A

3-Years Forward

EV/EBITDA

N/A

	Franklin Covey Co NYSE:FC	36.41 USD -1.03%
	Mohawk Industries Inc NYSE:MHK	119.16 USD 2%
	Ardmore Shipping Corp NYSE:ASC	11.31 USD 0.18%
	ASGN Inc NYSE:ASGN	83.87 USD -0.97%
	Skyworks Solutions Inc NASDAQ:SWKS	88.75 USD 0.56%
	Weatherford International PLC NASDAQ:WFRD	67.1 USD -2.13%

	Johnson & Johnson NYSE:JNJ	144.47 USD 0.62%
	Bank of America Corp NYSE:BAC	44.17 USD 1.82%
	Mastercard Inc NYSE:MA	528.03 USD 0.91%
	Salesforce Inc NYSE:CRM	343.65 USD 2.21%
	Abbvie Inc NYSE:ABBV	175.58 USD 2.37%
	Home Depot Inc NYSE:HD	392.6 USD 1.97%

	Arista Networks Inc NYSE:ANET	112.81 USD 3.43%
	Visa Inc NYSE:V	317.71 USD 0.9%
	Texas Pacific Land Corp NYSE:TPL	1 133.12 USD 3.36%
	KLA Corp NASDAQ:KLAC	629.37 USD 1.16%
	Manhattan Associates Inc NASDAQ:MANH	280.26 USD -0.81%
	Pinduoduo Inc NASDAQ:PDD	99.51 USD -1.48%

	Salesforce Inc NYSE:CRM	343.65 USD 2.21%
	Accenture PLC NYSE:ACN	366.37 USD -1.56%
	ServiceNow Inc NYSE:NOW	1 091.25 USD 1.52%
	EOG Resources Inc NYSE:EOG	119.04 USD 0.69%
	Copart Inc NASDAQ:CPRT	58.22 USD -0.39%
	Applied Materials Inc NASDAQ:AMAT	163.59 USD 1.33%

MannKind Corp
NASDAQ:MNKD

EV/EBITDA
Enterprise Value to EBITDA

EV/EBITDA Forward Multiples

See Also

Company

Help

Tools

Stocks

MannKind Corp NASDAQ:MNKD

EV/EBITDA Enterprise Value to EBITDA

EV/EBITDA Forward Multiples

See Also

Company

Help

Tools

Stocks

MannKind Corp
NASDAQ:MNKD

EV/EBITDA
Enterprise Value to EBITDA